Worst performer by far was OPTI:Optibiotix dropping 16%. I guess I can't be too despondent as they are still up by 37% compared to a few months ago when they were making a loss. It just seems that good news drives the price down, as there was more good news this week. I desperately want to see the RNS announcing Go Figure products in a major UK retailer - it's been hinted at for about a year so surely something must be due soon. Plus, it would be far easier buying my shakes from a shop than getting them posted from the online store, especially as we'll no longer be allowed to receive personal parcels at work from next month. More misery!
KIBO:Kibo Energy dropped 6% as the never-ending wait for a Power Purchase Agreement continues. I'm beginning to think it's never going to happen and I'll just carry on sitting on a 43% loss or watch it deepen.
PAF:Pan African Resources had finally gone into profit, but a downbeat trading statement caused a 10% crash despite containing no surprises. Fortunately the net effect was a 5% drop over the week and these are still 2% in profit. I'm hoping if they can stay in profit after that, then they can stay in profit for good. Dividend ex-date is usually October, although I'm not expecting very much this year. Production starting up at the new mine ought to have a much more significant positive effect on the share price.
Only two shares making big gains this month. RED:RedT Energy reversed last week's 6% drop with a 6% rise, but i was expecting more after announcing a deal to provide energy storage for the NHS. Only one trial site to begin with, but lets face it - the technology works and it's likely they will end up supplying the whole estate - and that's huge.
WRES:W Resources wins Share of the Week after an 8% rise despite the fact I don't really like it and wish I'd never bought it. There is hope that the price will recover when they start producing next year. However their debts are massive, their share dilution epic, and I just don't like the CEO one bit. If I can sell without making a loss I'll be happy. I only invested £430 so ideally I'd get £500 back so there's enough to use on something else.
Actually, it's possible SBTX:SkinBioTherapeutics is Share of the Week. I just noticed that I forgot to add it to my weekly snapshot list on the blog, and I can't remember how much it's climbed this week. However it's up 21% overall and I'm sure this week's rise was more than 8% and I like it much more, so tough luck WRES:W Resources you've had your award nicked!
Only one word for that - misery!
Here's the ISA and share portfolios performance
| Weekly Change | |||
| Cash | £6.61 | +£0 | |
| Portfolio cost | £56,958.55 | +£0 | |
| Portfolio sell value (bid price - commission) | £62,165.23 | (9.1%) | -£4,737.34 |
| Potential profits | £12,788.64 | -£4,678.87 | |
| Yr 4 Dividends | £29.56 | +£0 | |
| Yr 4 Profit from sales | £814.53 | +£0 | |
| Yr 4 Average monthly cash profit | £604.20 | (12.7%) | -£120.84 |
| Total Dividends | £1,267.89 | +£0 | |
| Total Profit from sales | £19,511.65 | +£0 | |
| Average monthly cash profit | £551.71 | (11.6%) | -£3.43 |
| (Sold stocks profit + Dividends - Fees / Months) |
OPTI:Optibiotix is responsible for most of the damage, but losses deepened on top of the reduced profit, so all bad really.
Not happy.
The SIPP looks like this after week 146
| Weekly Change | |||
| Cash | £42.83 | +£0 | |
| Portfolio cost | £27,893.76 | +£0 | |
| Portfolio sell value (bid price - commission) | £31,735.16 | (13.8%) | -£2,495.75 |
| Potential profits | £7,033.57 | -£2,395.03 | |
| Yr 3 Dividends | £292.57 | +£0 | |
| Yr 3 Profit from sales | £1,619.73 | +£0 | |
| Yr 3 Average monthly cash profit | £185.87 | (8%) | -£4.53 |
| Total Dividends | £1,208.67 | +£0 | |
| Total Profit from sales | £10,544.92 | +£0 | |
| Average monthly cash profit | £341.18 | (14.7%) | -£2.35 |
| (Sold stocks profit + Dividends - Fees / Months) |
Exactly the same story as above
Exactly the same misery as above
The trading account looks like this after week 112
| Weekly Change | |||
| Cash | £151.47 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,916.17 | (-17.5%) | -£18.14 |
| Potential profits | £94.56 | -£16.80 | |
| Year 3 Dividends | £0 | +£0 | |
| Year 3 Profit | £177.06 | +£0 | |
| Yr 3 Average monthly cash profit | £95.91 | (49.6%) | -£13.70 |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£2.44 | (-1.3%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
Hoped I could sell TAP:Taptica this week and get into the black, but it dropped in value rather then continuing the re-rate. Ups and downs elsewhere ended up with losses deepening a tiny bit too.
Nope - can't think of anything positive to say about that either.
Glad that blog post is out of the way - no fun to write and probably even less to read.
Please let next week be better...
No comments:
Post a Comment